Stock Updates: Cyclo Therapeutics, Lucy Scientific, Pasithea Therapeutics and Apple Making Waves
- June 05th, 2023
- 493 views
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) has entered into a binding agreement with Rafael Holdings, Inc. (NYSE: RFL).
Under the agreement, Rafael will acquire 4,000,000 shares of CYTH's common stock, along with warrants to purchase an additional 4,000,000 shares, for a total purchase price of $5,000,000.
$CYTH is currently trading at $1.42, reflecting a slight increase of $0.01 (+0.71%).
In other news, Lucy Scientific Discovery Inc. (Nasdaq: LSDI) has made a proposal to acquire Pasithea Therapeutics Corp. (Nasdaq: KTTA) through a cash-and-stock transaction.
The proposal suggests a per-share acquisition price of $0.85, comprising $0.60 in cash and $0.25 in Lucy stock.
Trading for both $LSDI and $KTTA has been halted in light of this development.
Additionally, BofA Securities has raised the price target for Apple Inc. (Nasdaq: AAPL) from $176 to $190, while Evercore ISI Group increased it from $190 to $210.
Currently, $AAPL is trading at $183.58, reflecting a positive movement of $2.63 (+1.45%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login